The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review)
Oncology Reports · 23.01.2024 · 51 (3)
DOI: 10.3892/or.2024.8707 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 23.01.2024. Verfasst von Andrea Pensotti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Philosophy of Science and Human Development, University Campus Bio‑Medico of Rome, I‑00128 Rome, Italy. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Unit of Philosophy of Science and Human Development, University Campus Bio‑Medico of Rome, I‑00128 Rome, Italy.
- Systems Biology Group Lab, Department of Experimental Medicine, Sapienza University, I‑00185 Rome, Italy.
Zitieren
APA
Pensotti, A., Bizzarri, M., & Bertolaso, M. (2024). The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review). Oncology Reports, 51(3). https://doi.org/10.3892/or.2024.8707
Vancouver
Pensotti A, Bizzarri M, Bertolaso M. The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review). Oncology Reports. 2024;51(3). doi:10.3892/or.2024.8707
BibTeX
@article{Pensotti2024,
author = {Pensotti, Andrea and Bizzarri, Mariano and Bertolaso, Marta},
title = {The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review)},
journal = {Oncology Reports},
year = {2024},
volume = {51},
number = {3},
doi = {10.3892/or.2024.8707}
}
EUVIMED